“…Because the once-daily dosing regimen recommended by the AHA allows outpatient therapy, OPAT with ceftriaxone or other drugs in patients with infectious endocarditis has been reported [13,17]. Although indications for OPAT vary among reports, commonly cited requirements include the absence of complications of infectious endocarditis, known causal organism and sensitivity, and support from the family [13,17,18]. Although careful selection of patients is necessary when OPAT is used for infectious endocarditis, the safety and efficacy of OPAT are expected to be equivalent to those of inpatient treatment [19].…”